Adial pharmaceuticals receives approval to commence phase 3 trial in finland

Adial pharmaceuticals inc - receives approval to commence phase 3 study to investigate ad04 for treatment of alcohol use disorder in finland.
ADIL Ratings Summary
ADIL Quant Ranking